Effect of dexamethasone on newborn survival at different administration-to-birth intervals: A secondary analysis of the WHO ACTION (Antenatal CorticosTeroids for Improving Outcomes in Preterm Newborn)-I trial

O. T. Oladapo,J. P. Vogel,G. Piaggio,M. H. Nguyen,F. Althabe,R. Bahl,S. P. Rao,A. D. Costa,S. Gupta,A. H. Baqui,M. Shahidullah,S. B. Chowdhury,S. S. Goudar,S. M. Dhaded,Z. P. Qureshi,F. Were,J. Kinuthia,A. I. Ayede,O. A. Adesina,O. Kuti,E. A. Adejuyigbe,S. Ariff,S. B. Soofi,L. Sheikh,J. Carvalho,V. A. Nilsson and L. Abreu. Effect of dexamethasone on newborn survival at different administration-to-birth intervals: A secondary analysis of the WHO ACTION (Antenatal CorticosTeroids for Improving Outcomes in Preterm Newborn)-I trial. EClinicalMedicine. 2022;53:10.1016/j.eclinm.2022.101744.